Shelby Chavez Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 102 Bill Jackson Dr, Alvarado, TX 76009 Phone: 817-783-6800 |
Wendy Marie Harms Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1500 N Cummings Dr, Alvarado, TX 76009 Phone: 817-783-6863 |
News Archive
PEPFAR on Wednesday "announced awards for a new initiative totaling $45 million over four years to examine the effectiveness of combination approaches to HIV prevention. These evaluations of combination prevention will be the largest and most robust to date. Data gathered will help partner countries to strengthen their efforts to prevent new infections and save lives," according to a State Department press release.
GlaxoSmithKline and Genmab A/S announced today an amendment to the ofatumumab co-development and commercialisation agreement. Under the terms of the amendment, GSK will take responsibility for developing ofatumumab in autoimmune indications whilst continuing to jointly develop ofatumumab with Genmab in oncology indications.
Mylan Inc. today announced that in accordance with its 2.139 million preferred stock issuance, the company has declared its quarterly dividend of $16.25 per share (based on the annual dividend rate of 6.5% and a liquidation preference of $1,000.00 per share) payable on May 17, 2010, to holders of preferred stock of record as of May 1, 2010.
AdherenceRx (www.adherencerx.com) is pleased to announce the development & integration of the Patient Adherence Index™ (PAI™). This new index brings together evidence-based patient behavior mapping scores associated with Positive Psychology & Behavior Change… and the Patient Activation Measure™ (PAM™) developed by Judith Hibbard, Ph.D., and her colleagues at the University of Oregon.
› Verified 5 days ago